A Study for Patients With Relapsing Remitting Multiple Sclerosis

NCT00869986 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: dirucotide
DRUG: placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]